Evidence map›Paper›PMID 41378739›Full record

ArticleStatistics in medicine2025

Effects Among the Affected.

Lina M Montoya, Elvin H Geng, Michael Valancius, Michael R Kosorok, Maya L Petersen

Registry-linked trialAbstract read
In one paragraph

Article in Statistics in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02338739 (An Adaptive Strategy for Preventing and Treating Lapses of Retention in Adult HIV Care), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02338739 nacompletednot on this map

An Adaptive Strategy for Preventing and Treating Lapses of Retention in Adult HIV Care (AdaPT-R)

TypeinterventionalSponsorUniversity of California, San FranciscoRan2015 to 2020Enrolled1,816ConditionsHIVArmsREC, Outreach if Failure, REC, SMS + Voucher if Failure, REC
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lina M MontoyaSchool of Data Science and Society, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID https://orcid.org/0000-0002-0975-4306
Elvin H GengDivision of Infectious Diseases, Washington University in St. Louis, Saint Louis, Missouri, USA.
Michael ValanciusDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Michael R KosorokDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Maya L PetersenDivision of Biostatistics, University of California, Berkeley, Berkeley, California, USA.

Funding

Targeted Learning using adaptive designs for HIV Epidemic control in East AfricaR01AI074345 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI PETERSEN, MAYA LIV, VANDERLAAN, MARK J · 2007 to 2023
$6.6M
Adaptive Strategies to Prevent and Treat Lapses of Retention in HIV Care for Adolescents (A4A)R01NR018801 · NINR · WASHINGTON UNIVERSITY · PI ABUOGI, LISA LYNN, GENG, ELVIN H. · 2019 to 2023
$2.9M
What works, for whom? Applying novel precision medicine methods to people with mental illness in the justice system.R00MH133985 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MONTOYA, LINA · 2024 to 2025
$729k
What works, for whom? Applying novel precision medicine methods to people with mental illness in the justice system.K99MH133985 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MONTOYA, LINA · 2023 to 2023
$100k
NIAID NIH HHS R01 AI074345NIH HHS R00MH133985NIH HHS R01AI074345NIMH NIH HHS K99 MH133985NIMH NIH HHS R00 MH133985NINR NIH HHS R01 NR018801
6 · The paper itself

Abstract

We propose a novel causal estimand that elucidates how response to an earlier treatment (e.g., treatment initiation) modifies the effect of a later treatment (e.g., treatment discontinuation), thus learning if there are effects among the (un)affected. Specifically, we consider a working marginal structural model summarizing how the average effect of a later treatment varies as a function of the (estimated) conditional average effect of an earlier treatment. We define the estimand to be a data-adaptive causal parameter, allowing for estimation of the conditional average treatment effect using machine learning without making strong smoothness assumptions. We show how a sequentially randomized design can be used to identify this causal estimand, and we describe a targeted maximum likelihood estimator for the resulting statistical estimand, with influence curve-based inference. We present simulation studies that evaluate the performance of this estimator under various finite-sample scenarios. Throughout, we use the "Adaptive Strategies for Preventing and Treating Lapses of Retention in HIV Care" trial (NCT02338739) as an illustrative example, showing that discontinuation of conditional cash transfers for HIV care adherence was most harmful among those who had an increase in benefit from them initially.

Indexed as

Models, StatisticalCausalityComputer SimulationHIV InfectionsHumansLikelihood FunctionsMachine LearningRandomized Controlled Trials as TopicTreatment Outcomeconditional average treatment effectdata‐adaptive parametermarginal structural modelsequential multiple assignment randomized trialtargeted maximum likelihood estimation

Identifiers

PMID41378739
PMCPMC12801280

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.